Ulrik Gether
Ulrik Gether
Verified email at sund.ku.dk
Title
Cited by
Cited by
Year
Uncovering molecular mechanisms involved in activation of G protein-coupled receptors
U Gether
Endocrine reviews 21 (1), 90-113, 2000
15552000
G protein-coupled receptors II. Mechanism of agonist activation
U Gether, BK Kobilka
Journal of Biological Chemistry 273 (29), 17979-17982, 1998
7711998
Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6
JA Ballesteros, AD Jensen, G Liapakis, SGF Rasmussen, L Shi, U Gether, ...
Journal of Biological Chemistry 276 (31), 29171-29177, 2001
7112001
SLC6 neurotransmitter transporters: structure, function, and regulation
AS Kristensen, J Andersen, TN Jørgensen, L Sørensen, J Eriksen, ...
Pharmacological reviews 63 (3), 585-640, 2011
6212011
Correlation between genetic and geographic structure in Europe
O Lao, TT Lu, M Nothnagel, O Junge, S Freitag-Wolf, A Caliebe, ...
Current Biology 18 (16), 1241-1248, 2008
5232008
Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor
U Gether, S Lin, P Ghanouni, JA Ballesteros, H Weinstein, BK Kobilka
The EMBO journal 16 (22), 6737-6747, 1997
4721997
[Leu31, Pro34] neuropeptide Y: a specific Y1 receptor agonist
J Fuhlendorff, U Gether, L Aakerlund, N Langeland-Johansen, ...
Proceedings of the National Academy of Sciences 87 (1), 182-186, 1990
4351990
Maltose–neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins
PS Chae, SGF Rasmussen, RR Rana, K Gotfryd, R Chandra, MA Goren, ...
Nature methods 7 (12), 1003-1008, 2010
3902010
How curved membranes recruit amphipathic helices and protein anchoring motifs
NS Hatzakis, VK Bhatia, J Larsen, KL Madsen, PY Bolinger, AH Kunding, ...
Nature chemical biology 5 (11), 835-841, 2009
3542009
Neurotransmitter transporters: molecular function of important drug targets
U Gether, PH Andersen, OM Larsson, A Schousboe
Trends in pharmacological sciences 27 (7), 375-383, 2006
3432006
The binding sites for cocaine and dopamine in the dopamine transporter overlap
T Beuming, J Kniazeff, ML Bergmann, L Shi, L Gracia, K Raniszewska, ...
Nature neuroscience 11 (7), 780-789, 2008
3412008
Fluorescent Labeling of Purified β2 Adrenergic Receptor EVIDENCE FOR LIGAND-SPECIFIC CONFORMATIONAL CHANGES
U Gether, S Lin, BK Kobilka
Journal of Biological Chemistry 270 (47), 28268-28275, 1995
3231995
Structural instability of a constitutively active G protein-coupled receptor: Agonist-independent activation due to conformational flexibility
U Gether, R Seifert, JA Ballesteros, E Sanders-Bush, H Weinstein, ...
Journal of Biological Chemistry 272 (5), 2587-2590, 2001
3112001
Mutation of a highly conserved aspartic acid in the β2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane …
SGF Rasmussen, AD Jensen, G Liapakis, P Ghanouni, JA Javitch, ...
Molecular pharmacology 56 (1), 175-184, 1999
2631999
Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype
C Martinat, JJ Bacci, T Leete, J Kim, WB Vanti, AH Newman, JH Cha, ...
Proceedings of the National Academy of Sciences 103 (8), 2874-2879, 2006
2532006
Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist
U Gether, TE Johansen, RM Snider, JA Lowe, S Nakanishi, TW Schwartz
Nature 362 (6418), 345-348, 1993
2451993
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport
JU Fog, H Khoshbouei, M Holy, WA Owens, CB Vaegter, N Sen, ...
Neuron 51 (4), 417-429, 2006
2322006
Amphipathic motifs in BAR domains are essential for membrane curvature sensing
VK Bhatia, KL Madsen, PY Bolinger, A Kunding, P Hedegård, U Gether, ...
The EMBO journal 28 (21), 3303-3314, 2009
2312009
Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the β2 adrenergic receptor mapped by site-selective fluorescent labeling
AD Jensen, F Guarnieri, SGF Rasmussen, F Asmar, JA Ballesteros, ...
Journal of Biological Chemistry 276 (12), 9279-9290, 2001
2012001
A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations
J Dal Porto, TE Johansen, B Catipović, DJ Parfiit, D Tuveson, U Gether, ...
Proceedings of the National Academy of Sciences 90 (14), 6671-6675, 1993
2011993
The system can't perform the operation now. Try again later.
Articles 1–20